Press release
Exporters Worlds Releases 2025 Compliance Guide After US Removes Tariffs on Indian Spices
Exporters Worlds releases 2025 Advisory on US Tariff Cuts & FDA Safety Checks
Exporters Worlds, a leading B2B verification platform for Indian exporters, has released a critical advisory for US-based importers following the White House's November 12th executive order. The order, which exempts Indian spices including Turmeric, Pepper, and Cumin from the previous 50% reciprocal tariffs, has opened a significant arbitrage opportunity for international buyers.
While the tariff reduction lowers landing costs by approximately 20-30%, industry data indicates a simultaneous rise in compliance risks. FDA refusals for Indian spice shipments reached a record high in late 2024, primarily due to Salmonella citations.
"The opportunity for US importers is massive right now, but the compliance bar has been raised," says Arpit Chaudhary, Executive at Exporters Worlds. "We are seeing a surge in demand for verified manufacturers who possess Steam Sterilization (ETO) certificates, which is now the only reliable safeguard against FDA detention."
To assist global buyers in navigating these new regulations, Exporters Worlds has published a comprehensive 2025 Spice Import Checklist. The guide covers:
HS Code classifications for the newly exempted spice categories.
FSVP (Foreign Supplier Verification Program) requirements for 2025.
Mandatory certifications including FSSAI, ISO 22000, and Organic NOP.
About Exporters Worlds Exporters Worlds is a premier B2B portal connecting global importers with verified Indian manufacturers. Unlike standard directories, it focuses on factory-direct sourcing to ensure price transparency and quality compliance.
For more information or to access the verified supplier list, visit: https://exportersworlds.com/
- Exporters Worlds
- J1/104,near by cylinder Chauraha, Keshavpuram, Awas Vikas Number 1, Kalyanpur, Kanpur, Uttar Pradesh 203017
- (+91)-95558 87685
- help@exportersworlds.com
Exporters Worlds is an Indian B2B (business-to-business) marketplace that connects exporters with international buyers and suppliers. Established in 2015, it provides a platform for businesses to find reliable partners, showcase products, and expand their reach globally. The platform offers services like trade alerts, buyer leads, and various consultancy and digital services to help businesses with their export and import needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exporters Worlds Releases 2025 Compliance Guide After US Removes Tariffs on Indian Spices here
News-ID: 4286487 • Views: …
More Releases for FDA
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
